A MAN has died after suffering
severe side effects during a drug
trial in France, while five other
volunteers have been hospitalised.
A private laboratory was testing
a new pain medication on humans
for the first time, on behalf of
Portuguese drugmaker Bial.
Out of the 108 volunteers
participating, 90 received the drug
in varying dosages and the rest
were given placebos.
The trial has been halted and Bial
is cooperating with an investigation.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jan 16
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.